Indivior PLC (LSE:INDV) - Share price - Overview

Stock Report

Indivior PLC INDV

Last Price
GBX325.10

Day Change
9.00|2.85%

As of 22/09/2017
17:02:05 BST | GBX
Minimum 15 Minutes Delay.

Last Close316.10p
Day Range313.00 - 327.90
Mkt Cap2.28Bil
52-Wk Range246.50 - 421.50
Yield %2.25
ISINGB00BRS65X63
Volume2,931,230
P/E12.68
P/S2.99
P/CF7.76

Share Price

Total Returns 21/09/2017

 Chg (%)  
More ...
Indivior PLC-22.35 
FTSE 100 TR GBP-0.61
 
Financials
201420152016
More ...
Income Statement
Turnover678.46663.69783.77
Operating Profit341.97226.47110.38
Net Profit245.22149.2325.93
Reported EPS34.0820.293.70
Balance Sheet
Current Assets363.00489.18801.20
Non Current Assets116.93146.55177.24
Total Assets479.93635.73978.43
Current Liabilities296.83409.12833.57
Total Liabilities785.11825.021,217.17
Total Equity-305.18-189.29-238.74
Cash Flow
Operating Cash Flow303.63323.99379.29
Net Change in Cash197.1594.91166.68
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017-28.6411.7311.040.94--
2018-28.56-0.2711.07-41.16--
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
24/02/2017PurchaseMs. Liz Zlatkus341.606962,378.00
24/02/2017PurchaseDr. Yvonne Greenstreet341.601,4194,847.00
24/02/2017PurchaseMs. Lorna Parker341.601,2314,205.00
24/02/2017PurchaseMr. Daniel Phelan341.602,0697,068.00

Company Profile

Indivior PLC is a US-based specialty and generic drug manufacturing company. The firm develops, manufactures, and sells prescription drugs that are mainly based on buprenorphine for treatment of opioid dependence.

Sector

Drug Manufacturers - Specialty & Generic

Market Position

179 of 1837 Companies

Index

FTSE 250 ,FTSE 350 ,FTSE All Share

Outlook

(27/07/2017) no outlook statement

Next Event 02/11/2017

Next Q3 announcement
Ratios
CompSecMkt
More ...
PER (E)11.0612.9416.05
Div Yld (E)0.004.054.18
PEG (E)3.920.730.90
ROCE166.35191.3613.73
Op Mrgn33.84-4.32-15.22
EPS Grwth2.8221.8819.70
Dividends
PreviousLatest
More ...
Record Date18/09/1517/06/16
Ex-Div17/09/1516/06/16
Paid23/10/1529/07/16
Amnt2.087.30

Broker Sentiment

Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Howard Pien
Chief Executive OfficerMr. Shaun Thaxter
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.